SCHEMBL2845133

SCHEMBL2845133

O=C(Cc1ccc2ccccc2c1)N1CC=C(c2cccc(C(F)(F)F)c2)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.50
▸ KMT2A Q03164 3/20 0.50
▸ CYP1A2 P05177 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2D6 P10635 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ PPARG P37231 1/20 0.45
▸ PPARA Q07869 1/20 0.45
▸ CCR2 P41597 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ SYK P43405 1/20 0.43
▸ OPRL1 P41146 1/20 0.42
▸ RIOK2 Q9BVS4 1/20 0.41
▸ HTR2C P28335 2/20 0.41
▸ HTR7 P34969 1/20 0.41
▸ SOS1 Q07889 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8742178 0.91 MEN1 (0.48) MEN1KMT2ACYP1A2CYP3A4CYP2D6
SCHEMBL10939339 0.91 MEN1 (0.50) MEN1KMT2APPARGPPARACCR2
SCHEMBL8742167 0.90 PPARG (0.47) MEN1KMT2ACYP1A2CYP3A4CYP2D6
SCHEMBL8742207 0.89 KMT2A (0.45) MEN1KMT2ACYP1A2CYP3A4CYP2D6
SCHEMBL2845134 0.84 KDM4E (0.47) MEN1KMT2ACYP2C9CCR2KDM4E
SCHEMBL10935421 0.81 MEN1 (0.49) MEN1KMT2ACYP1A2CYP3A4CYP2D6
SCHEMBL9423057 0.81 CCR2 (0.46) MEN1KMT2APPARGPPARACCR2
SCHEMBL187309 0.81 MEN1 (0.50) MEN1KMT2ANPSR1PPARGPPARA
Xaliproden SCHEMBL137094 0.81 SIGMAR1 (0.51) MEN1KMT2APPARGPPARAKDM4E
Xaliproden SCHEMBL29377982 0.81 SIGMAR1 (0.51) MEN1KMT2APPARGPPARAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100021541-A1 Microparticulate form of a Tetrahydropyridine derivative SANOFI-AVENTIS (FR) 2010-01-28 — — US disclosed
US-20080255365-A1 Microparticulate form of a Tetrahydropyridine derivative SANOFI-AVENTIS (FR) 2008-10-16 — — US disclosed
EP-0950051-B1 MICRO-PARTICULATE FORM OF A TETRAHYDROPYRIDIN DERIVATIVE SANOFI SYNTHELABO (FR) 2003-09-17 — — EP disclosed
US-20020192292-A1 Microparticulate form of a tetrahydropyridin derivative SANOFI-AVENTIS (FR) 2002-12-19 — — US disclosed
US-20020028247-A1 MICRO-PARTICULATE FORM OF A TETRAHYDROPYRIDIN DERIVATIVE SANOFI-SYNTHEALBO (FR) 2002-03-07 — — US disclosed
EP-0950051-A1 MICRO-PARTICULATE FORM OF A TETRAHYDROPYRIDIN DERIVATIVE SANOFI-SYNTHELABO (FR) 1999-10-20 — — EP disclosed
WO-1998028272-A1 MICRO-PARTICULATE FORM OF A TETRAHYDROPYRIDIN DERIVATIVE SANOFI (FR) 1998-07-02 — — WO disclosed
EP-0101381-B1 ANOREXIC TRIFLUOROMETHYL PHENYL TETRAHYDROPYRIDINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SANOFI S.A. (FR) 1985-12-04 — — EP disclosed
US-4521428-A Anorexigenic trifluoromethylphenyltetrahydropyridines and pharmaceutical compositions containing them SANOFI (FR) 1985-06-04 — — US disclosed
EP-0101381-A1 Anorexic trifluoromethyl phenyl tetrahydropyridines, process for their preparation and pharmaceutical compositions containing them SANOFI S.A. (FR) 1984-02-22 — — EP disclosed
Send feedback